Products Categories
| CAS No.: | 13510-49-1 |
|---|---|
| Name: | BERYLLIUM SULFATE |
| Molecular Structure: | |
|
|
|
| Formula: | Be. H2 O4 S |
| Molecular Weight: | 105.07 |
| Synonyms: | Berylliumsulfate (6CI,7CI); Beryllium sulfate (BeSO4) |
| EINECS: | 236-842-2 |
| Density: | 2.500 |
| Melting Point: | 1127°C |
| Boiling Point: | 330°C at 760 mmHg |
| Solubility: | g/100g solution H2O: 26.69 (0°C), 29.22 (25°C), 45.28 (100°C); solid phase, BeSO4 · 4H2O [KRU93]; insoluble alcohol [HAW93] |
| Hazard Symbols: | A carcinogen (OSHA). TLV: 0.002 (Be)mg/m3; Confirmed Human Carcinogen |
| Safety: | Confirmed carcinogen with experimental tumorigenic data. Acute poison by inhalation, ingestion, intraperitoneal, subcutaneous, intravenous, and intratracheal routes. See also BERYLLIUM COMPOUNDS and SULFATES. Mutation data reported. When heated to decomposition it emits very toxic fumes of SOx and BeO. |
| PSA: | 82.98000 |
| LogP: | 0.42800 |
- 144851-82-1METHYL2-AMINO-3-FLUOROBENZOATE
- 483366-12-7(2S,4R)-1-Boc-2-cyano-4-hydroxypyrrolidine
- 173606-50-3BOC-10-AMINODECANOIC ACID
- 361456-36-2METHYL (R)-(+)-ISOCYANATO-3-PHENYLPROPI&
- 5156-58-1N-(1-Benzyl-4-pipperidinyl)-N-phenylpropanamide HCl
- 81281-59-67-Benzylideneaminotheophylline
- 50288-62-5threo-Phenyl-2-piperidyl acetamide
- 82993-81-5D-threo-Ritalinic acid hydrochloride
- 47087-37-6Z-D-Glu-OMe
- 73441-42-6METHYL-5-CHLORO-2,2-DIMETHYLVALERATE
- Total:7 Page 1 of 1 1
What can I do for you?
Get Best Price
Chemistry
Molecular Formula: BeH2O4S
Molar mass: 107.090662 g/mol
EINECS: 236-842-2
Structure of Beryllium sulfate (1:1) (13510-49-1):
XLogP3-AA: 1.3
H-Bond Donor: 2
H-Bond Acceptor: 4
IUPAC Name: Beryllium; sulfuric acid
Canonical SMILES: [Be].OS(=O)(=O)O
InChI: InChI=1S/Be.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4)
InChIKey: ILZUVMDSMZZEPE-UHFFFAOYSA-N
Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| cat | LCLo | inhalation | 10mg/m3 (10mg/m3) | Environmental Quality and Safety, Supplement. Vol. 1, Pg. 1, 1975. | |
| dog | LDLo | intratracheal | 1000ug/kg (1mg/kg) | U.S. Public Health Service Publication. Vol. 2173, Pg. 23, 1972. | |
| dog | LDLo | intravenous | 600ug/kg (0.6mg/kg) | U.S. Public Health Service Publication. Vol. 2173, Pg. 23, 1972. | |
| guinea pig | LC50 | inhalation | 47mg/m3 (47mg/m3) | Environmental Quality and Safety, Supplement. Vol. 1, Pg. 1, 1975. | |
| guinea pig | LDLo | intraperitoneal | 100mg/kg (100mg/kg) | National Institutes of Health, Bulletin. Vol. 181, Pg. 1, 1943. | |
| monkey | LDLo | intratracheal | 1000ug/kg (1mg/kg) | U.S. Public Health Service Publication. Vol. 2173, Pg. 23, 1972. | |
| monkey | LDLo | intravenous | 600ug/kg (0.6mg/kg) | U.S. Public Health Service Publication. Vol. 2173, Pg. 23, 1972. | |
| mouse | LCLo | inhalation | 47mg/m3 (47mg/m3) | Environmental Quality and Safety, Supplement. Vol. 1, Pg. 1, 1975. | |
| mouse | LD50 | intraperitoneal | 1200mg/kg (1200mg/kg) | JNCI, Journal of the National Cancer Institute. Vol. 62, Pg. 911, 1979. | |
| mouse | LD50 | intravenous | 500ug/kg (0.5mg/kg) | U.S. Public Health Service Publication. Vol. 2173, Pg. 23, 1972. | |
| mouse | LD50 | oral | 80mg/kg (80mg/kg) | Hygiene and Sanitation Vol. 30(1-3), Pg. 169, 1965. | |
| mouse | LD50 | subcutaneous | 1500ug/kg (1.5mg/kg) | U.S. Public Health Service Publication. Vol. 2173, Pg. 23, 1972. | |
| rabbit | LCLo | inhalation | 10mg/m3 (10mg/m3) | Environmental Quality and Safety, Supplement. Vol. 1, Pg. 1, 1975. | |
| rabbit | LD50 | subcutaneous | 1500ug/kg (1.5mg/kg) | U.S. Public Health Service Publication. Vol. 2173, Pg. 23, 1972. | |
| rat | LCLo | inhalation | 10mg/m3 (10mg/m3) | Environmental Quality and Safety, Supplement. Vol. 1, Pg. 1, 1975. | |
| rat | LD50 | intravenous | 7200ug/kg (7.2mg/kg) | U.S. Public Health Service Publication. Vol. 2173, Pg. 23, 1972. | |
| rat | LD50 | oral | 82mg/kg (82mg/kg) | Hygiene and Sanitation Vol. 30(1-3), Pg. 169, 1965. | |
| rat | LD50 | subcutaneous | 1500ug/kg (1.5mg/kg) | U.S. Public Health Service Publication. Vol. 2173, Pg. 23, 1972. | |
| rat | LDLo | intraperitoneal | 18mg/kg (18mg/kg) | U.S. Public Health Service Publication. Vol. 2173, Pg. 23, 1972. | |
| rat | LDLo | intratracheal | 10mg/kg (10mg/kg) | U.S. Public Health Service Publication. Vol. 2173, Pg. 23, 1972. |
Consensus Reports
NTP 10th Report on Carcinogens. IARC Cancer Review: Group 1 IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 58 (1993),p. 41.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Human Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 58 (1993),p. 41.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 1 (1972),p. 17.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 23 (1980),p. 143.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 58 (1993),p. 41.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . Beryllium and its compounds are on the Community Right-To-Know List. Reported in EPA TSCA Inventory.
Safety Profile
Confirmed carcinogen with experimental tumorigenic data. Acute poison by inhalation, ingestion, intraperitoneal, subcutaneous, intravenous, and intratracheal routes. See also BERYLLIUM COMPOUNDS and SULFATES. Mutation data reported. When heated to decomposition it emits very toxic fumes of SOx and BeO.
Standards and Recommendations
OSHA PEL: TWA 0.002 mg(Be)/m3; STEL 0.005 mg(Be)/m3/30M; CL 0.025 mg(Be)/m3
ACGIH TLV: TWA 0.002 mg(Be)/m3; Confirmed Human Carcinogen; (Proposed: TWA 0.0002 mg(Be)/m3 (sensitizer); Confirmed Human Carcinogen)
NIOSH REL: (Beryllium) CL not to exceed 0.0005 mg(Be)/m3
Specification
Beryllium sulfate (1:1) (13510-49-1) also can be called Sulfuric acid, beryllium salt (1:1) ; 1Beryllium sulfate (6CI,7CI) ; Beryllium sulfate ;and Beryllium sulfate, BeSO4 . Beryllium sulfate (1:1) (13510-49-1) is incompatible with the following: Acids, caustics, chlorinated hydrocarbons, oxidizers, molten lithium .Fire Hazard Special Hazards of Combustion Products: Toxic beryllium oxide and sulfuric acid fumes may form in fire.Any dramatic, unexplained weight loss should be considered as possible first indication of beryllium disease. Inhalation causes pneumonitis, nasopharyngitis, tracheobronchitis, dyspnea, chronic cough. Contact with eyes causes conjunctival inflammation.Contact with skin causes dermatitis of primary irritant or sensitization type; causes ulcer formation when in contact with cuts.